featured
FOLFIRI in Patients With Metastatic Colorectal Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Annals of Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Subgroup Analysis in RAISE: A Randomized, Double-Blind Phase 3 Study of Irinotecan, Folinic Acid, And 5-Fluorouracil (FOLFIRI) Plus Ramucirumab or Placebo in Patients With Metastatic Colorectal Carcinoma Progression
Ann. Oncol 2016 Aug 29;[EPub Ahead of Print], R Obermannová, E Van Cutsem, T Yoshino, G Bodoky, J Prausová, R Garcia-Carbonero, T Ciuleanu, P Garcia Alfonso, D Portnoy, A Cohn, K Yamazaki, P Clingan, S Lonardi, TW Kim, L Yang, F Nasroulah, J TaberneroFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.